Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fishfa Biogenics is an Indian pharmaceutical company that specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) for both human and veterinary healthcare. Based in Rajkot, Gujarat, the company operates a modern manufacturing facility dedicated to producing high-quality anti-infectives, anthelmintics, and other essential medicinal compounds. Their product portfolio includes widely used generic APIs such as Enrofloxacin, Ciprofloxacin, and Albendazole, serving the poultry, livestock, and aquaculture industries globally. Fishfa Biogenics is part of the Fishfa Group and maintains rigorous quality standards, adhering to WHO-GMP guidelines to ensure international compliance. The company focuses on providing cost-effective bulk drug solutions to pharmaceutical formulators across various international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fishfa Biogenics.